Crossmark

Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice

Published Online: 2021-07-21

Authors

Rice, Adrian

Verma, Mohit

Shin, Annie

Zakin, Lise

Sieling, Peter

Tanaka, Shiho

Balint, Joseph

Dinkins, Kyle

Adisetiyo, Helty

Morimoto, Brett

Higashide, Wendy

Anders Olson, C.

Mody, Shivani

Spilman, Patricia

Gabitzsch, Elizabeth

Safrit, Jeffrey T.

Rabizadeh, Shahrooz

Niazi, Kayvan

Soon-Shiong, Patrick
License Information

Text and Data Mining valid from 2021-07-21

Version of Record valid from 2021-07-21
More Information

Article History

Received: 29 March 2021

Accepted: 7 July 2021

First Online: 21 July 2021

Competing interests

: All authors are affiliated with ImmunityBio, Inc. and have designed, tested, or supported studies of the vaccine described, a potential commercial product.

Document is current